Phosphoinositide 3‑kinase/protein kinase B regulates inflammation severity via signaling of Toll‑like receptor 4 in severe acute pancreatitis

Wang,Jing; Zhang,Chun; Xu,Ping; Yang,Zhi‑Wen; Weng,Cheng‑Zhao; Lai,Yue‑Xing

doi:10.3892/mmr.2018.8819

Phosphoinositide 3‑kinase/protein kinase B regulates inflammation severity via signaling of Toll‑like receptor 4 in severe acute pancreatitis

Authors:
- Jing Wang
- Chun Zhang
- Ping Xu
- Zhi‑Wen Yang
- Cheng‑Zhao Weng
- Yue‑Xing Lai
View Affiliations

Affiliations: Department of Gastroenterology, Shanghai Songjiang Hospital Affiliated to Nanjing Medical University, Shanghai 201600, P.R. China, Department of Pharmacy, Songjiang Hospital Affiliated Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China, Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai 200030, P.R. China
Published online on: March 29, 2018 https://doi.org/10.3892/mmr.2018.8819
Pages: 7835-7844

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (Akt) has been indicated to serve an important role in the pathogenesis of inflammatory diseases. It was previously demonstrated that the PI3K/Akt inhibitor wortmannin alleviated the severity of inflammation and improved the survival rate in rats with induced severe acute pancreatitis (SAP), which indicates that PI3K/Akt may serve a role in the pathogenesis of acute pancreatitis. To date, the mechanism by which PI3K/Akt regulates inflammation has not been elucidated. In the present study, it was hypothesized that PI3K/Akt may be invovled in SAP inflammation via regulation of the Toll‑like receptor 4 (TLR4) signaling pathway. Rats with SAP were treated with the PI3K/Akt agonist insulin‑like growth factor (IGF)‑1, which alleviated the severity of inflammation in a dose‑dependent manner. Furthermore, to better understand the role of PI3K/Akt in inflammation, RAW264.7 murine macrophages were stimulated with IGF‑1 and wortmannin alone or together before the induction of inflammation by treatment with lipopolysaccharide (LPS). The results indicated that LPS stimulated overexpression of TLR4, myeloid differentiation primary response gene 88 (MyD88), PI3K, Akt, p38MAPK and NF‑κBp65 mRNA, and increased the levels of tumor necrosis factor (TNF)‑α and interleukin (IL)‑6 in RAW264.7 cells compared with the control group. The levels of all detected factors were increased by stimulation with IGF‑1, whereas these levels were decreased following treatment with wortmannin alone, and the effect of IGF‑1 was abolished by wortmannin in RAW264.7 cells. In vivo studies indicated that IGF‑1 produced the same anti‑inflammatory effect as wortmannin and that expression of TLR4, p38MAPK and NF‑κBp65 decreased following treatment with IGF‑1. These findings indicate that PI3K/Akt may take part in the progression of SAP by regulating the TLR4 signaling pathway and that IGF‑1 can inhibit inflammation in SAP rats.

View Figures

View References

1	Chiang DT, Anozie A, Fleming WR and Kiroff GK: Comparative study on acute pancreatitis management. ANZ J Surg. 74:218–221. 2004. View Article : Google Scholar : PubMed/NCBI
2	Xu P, Wang J, Yang ZW, Lou XL and Chen C: Regulatory roles of the PI3K/Akt signaling pathway in rats with severe acute pancreatitis. PLoS One. 8:e817672013. View Article : Google Scholar : PubMed/NCBI
3	Troutman TD, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan JF and Pasare C: Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc Natl Acad Sci USA. 109:273–278. 2012. View Article : Google Scholar : PubMed/NCBI
4	Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell. 124:783–801. 2006. View Article : Google Scholar : PubMed/NCBI
5	Sharif R, Dawra R, Wasiluk K, Phillips P, Dudeja V, Kurt-Jones E, Finberg R and Saluja A: Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut. 58:813–819. 2009. View Article : Google Scholar : PubMed/NCBI
6	Ding JL, Zhou ZG, Zhou XY, Zhou B, Wang L, Wang R, Zhan L, Sun XF and Li Y: Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: The effect on toll-like receptor signaling pathways. Pancreas. 42:114–122. 2013. View Article : Google Scholar : PubMed/NCBI
7	Hoque R, Sohail M, Malik A, Sarwar S, Luo Y, Shah A, Barrat F, Flavell R, Gorelick F, Husain S and Mehal W: TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology. 141:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
8	Mogensen TH: Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 22:240–273. 2009. View Article : Google Scholar : PubMed/NCBI
9	Takeda K and Akira S: TLR signaling pathways. Semin Immunol. 16:3–9. 2004. View Article : Google Scholar : PubMed/NCBI
10	Gay NJ and Gangloff M: Structure and function of Toll receptors and their ligands. Annu Rev Biochem. 76:141–165. 2007. View Article : Google Scholar : PubMed/NCBI
11	Schmid RM and Adler G: NF-kappaB/rel/IkappaB: Implications in gastrointestinal diseases. Gastroenterology. 118:1208–1228. 2000. View Article : Google Scholar : PubMed/NCBI
12	Zarubin T and Han J: Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11–18. 2005. View Article : Google Scholar : PubMed/NCBI
13	Xu P, Zhou XJ, Chen LQ, Chen J, Xie Y, Lv LH and Hou XH: Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol. 13:1983–1988. 2007. View Article : Google Scholar : PubMed/NCBI
14	Wang J, Xu P, Hou YQ, Xu K, Li QH and Huang L: Pancreatitis-associated ascitic fluid induces proinflammatory cytokine expression in THP-1 cells by inhibiting anti-inflammatory signaling. Pancreas. 42:855–860. 2013. View Article : Google Scholar : PubMed/NCBI
15	Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT and Warshaw AL: A better model of acute pancreatitis for evaluating therapy. Ann Surg. 215:44–56. 1992. View Article : Google Scholar : PubMed/NCBI
16	LeRoith D, Werner H, Beitner-Johnson D and Roberts CT Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 16:143–163. 1995. View Article : Google Scholar : PubMed/NCBI
17	Zhang L, Yue Y, Ouyang M, Liu H and Li Z: The effects of IGF-1 on TNF-α-treated DRG neurons by modulating ATF3 and GAP-43 expression via PI3K/Akt/S6K signaling pathway. Neurochem Res. 42:1403–1421. 2017. View Article : Google Scholar : PubMed/NCBI
18	Metz M and Maurer M: Mast cells-key effector cells in immune responses. Trends Immunol. 28:234–241. 2007. View Article : Google Scholar : PubMed/NCBI
19	Konrad S, Ali SR, Wiege K, Syed SN, Engling L, Piekorz RP, Hirsch E, Nürnberg B, Schmidt RE and Gessner JE: Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation. J Biol Chem. 283:33296–33303. 2008. View Article : Google Scholar : PubMed/NCBI
20	González-García A, Sánchez-Ruiz J, Flores JM and Carrera AC: Phosphatidylinositol 3-kinase gamma inhibition ameliorates inflammation and tumor growth in a model of colitis-associated cancer. Gastroenterology. 138:1374–1383. 2010. View Article : Google Scholar : PubMed/NCBI
21	Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Matsumura N, Nakajima T and Kuroda Y: Expression of toll-like receptor 2 and 4 in intestinal mucosa in experimental severe acute pancreatitis. Hepatogastroenterology. 55:2247–2251. 2008.PubMed/NCBI
22	Zhang X, Zhu C, Wu D and Jiang X: Possible role of toll-like receptor 4 in acute pancreatitis. Pancreas. 39:819–824. 2010. View Article : Google Scholar : PubMed/NCBI
23	Awla D, Abdulla A, Regnér S and Thorlacius H: TLR4 but not TLR2 regulates inflammation and tissue damage in acute pancreatitis induced by retrograde infusion of taurocholate. Inflamm Res. 60:1093–1098. 2011. View Article : Google Scholar : PubMed/NCBI
24	Liu Y and Li Y, Chen KL, Zhou B, Lv ZY, Zhou ZG and Li Y: Knockdown of myeloid differentiation factor 88 attenuates lipopolysaccharide-induced inflammatory response in pancreatic ductal cells. Pancreas. 45:755–760. 2016. View Article : Google Scholar : PubMed/NCBI
25	Gorsky VA, Agapov MA, Khoreva MV and Leonenko IV: The effect of lornoxicam on TLR2 and TLR4 messenger RNA expression and tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion in patients with systemic complications of acute pancreatitis. Pancreas. 44:824–830. 2015. View Article : Google Scholar : PubMed/NCBI
26	Xu P, Xu K, Wang J, Jiang JP and Chen LQ: Pioglitazone: A promising therapeutic tool in sodium taurocholate-induced severe acute pancreatitis. Dig Dis Sci. 56:1082–1089. 2011. View Article : Google Scholar : PubMed/NCBI
27	Jiang D, Li D, Cao L, Wang L, Zhu S, Xu T, Wang C and Pan D: Positive feedback regulation of proliferation in vascular smooth muscle cells stimulated by lipopolysaccharide is mediated through the TLR 4/Rac1/Akt pathway. PLoS One. 9:e923982014. View Article : Google Scholar : PubMed/NCBI
28	Hochdörfer T, Kuhny M, Zorn CN, Hendriks RW, Vanhaesebroeck B, Bohnacker T, Krystal G and Huber M: Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal. 23:866–875. 2011. View Article : Google Scholar : PubMed/NCBI
29	Kim SY, Jeong E, Joung SM and Lee JY: PI3K/Akt contributes to increased expression of Toll-like receptor 4 in macrophages exposed to hypoxic stress. Biochem Biophys Res Commun. 419:466–471. 2012. View Article : Google Scholar : PubMed/NCBI
30	Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE and McCubrey JA: JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 18:189–218. 2004. View Article : Google Scholar : PubMed/NCBI
31	Kang X, Wang LZ, Wang YG, Liu L, Fan ZW, Bai LZ and Lu XG: Expression and significance of phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in severe acute pancreatitis-associated lung injury. Zhonghua Yi Xue Za Zhi. 90:732–737. 2010.(In Chinese). PubMed/NCBI
32	Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY and Rhee MH: Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology. 218:1452–1467. 2013. View Article : Google Scholar : PubMed/NCBI
33	Payne JF, Tangpricha V, Cleveland J, Lynn MJ, Ray R and Srivastava SK: Serum insulin-like growth factor-I in diabetic retinopathy. Mol Vis. 17:2318–2324. 2011.PubMed/NCBI
34	Yu X, Xing C, Pan Y, Ma H, Zhang J and Li W: IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs. Acta Biochim Biophys Sin (Shanghai). 44:746–751. 2012. View Article : Google Scholar : PubMed/NCBI
35	Warzecha Z, Dembinski A, Ceranowicz P, Konturek SJ, Tomaszewska R, Stachura J and Konturek PC: IGF-1 stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis. J Physiol Pharmacol. 54:575–590. 2003.PubMed/NCBI
36	Mankad P1, James A, Siriwardena AK, Elliott AC and Bruce JI: Insulin protects pancreatic acinar cells from cytosolic calcium overload and inhibition of plasma membrane calcium pump. J Biol Chem. 287:1823–1836. 2012. View Article : Google Scholar : PubMed/NCBI